Lepu Medical (Europe) Inc. Coöperatief U.A

Lepu Medical Technology (Beijing) Co., Ltd., established in 1999, is one of China's earliest enterprises engaged in the research and development of interventional cardiology medical devices. In 2009, Lepu Medical was successfully listed on the Shenzhen Stock Exchange’s Growth Enterprise Market (Stock Code: 300003). In 2022, Lepu Medical was also listed on the Swiss Stock Exchange (ISIN: US52678P2056). Our two subsidiaries, LEPU BIOPHARMA and Scientech, are also listed on the Hong Kong Stock Exchange. Our comprehensive product portfolio covers a wide range of medical fields, including Cardiovascular & Peripheral Products, In Vitro Diagnostics, Structural Heart Disease Products, Critical Care Products, Hemodialysis Products, ECG & Patient Monitoring & Telehealth Solutions, Pharmaceutical (API) Products, Surgical Products, Orthopedic Products, Cardiac Rhythm Management Products, and Digital Subtraction Angiography (DSA) Systems.